More than just B12 therapy - we offer complete primary care, weight loss programs, IV therapy, and mental health services all under one roof
The company started a phase 2 trial studying VK2735 in obese patients back in September 2023 with the purpose of assessing the safety and efficacy of the once weekly subcutaneous drug
Merit Pharmaceutical shall not be liable for any damageswhether direct, indirect, incidental, consequential, special, or otherwisearising out of or in connection with the use of, or reliance on, any information provided on this website.
It has a capacity of 1 mL and is marked in 0.1 mL increments , allowing for precise measurement of drugs in small doses
That way, they can observe your injection technique and provide feedback in the moment
Your Journey Meet with a BHRC physician to discuss your metabolic health goals and determine if 5-Amino-1MQ is right for you